COVID-19 Early Intervention Protocol (MATH+)

MATH+ protocol works with near-100% effectiveness, but it's been suppressed since its acceptance would negate protections for Big Pharma's mRNA treatment claim of being the only effective treatment.

This approach addresses the three core pathological processes seen in COVID-19, namely hyperinflammation, hypercoagulability of the blood, and hypoxia (shortness of breath due to low oxygenation).

MATH+ is an acronym for the protocols described below.

These protocols calls for the use of three medicines to start within six hours of hospital admission.

Intravenous Methylprednisolone

Intravenous methylprednisolone, to suppress the immune system and prevent organ damage from cytokine storms—For mild hypoxia, 40 milligrams (mg) daily until off oxygen; moderate to severe illness, 80 mg bolus followed by 20 mg per day for seven days. On day 8, switch to oral prednisone and taper down over the next six days.

High-dose intravenous Ascorbic acid

Intravenous ascorbic acid (vitamin C), to control inflammation and prevent the development of leaky blood vessels in the lungs—3 grams/100 ml every six hours for up to seven days.

Thiamine, zinc and vitamin D

Optional additions include thiamine, zinc and vitamin D. In addition to these medications, the protocol calls for high-flow nasal oxygen to avoid mechanical ventilation, which itself damages the lungs and is associated with a mortality rate approaching nearly 90% in some medical centers reporting.

Full-dose low molecular weight Heparin

Subcutaneous heparin (enoxaparin), to thin the blood and prevent blood clots—For mild to moderate illness, 40 mg to 60 mg daily until discharged.

It's crucial to treat each patient as an individual case, as COVID-19 is not conventional acute respiratory distress syndrome (ARDS).

If the patient is assumed to have ARDS and placed on a ventilator, lung damage will surely follow. Research over 2020 has shown that patients placed on mechanical ventilation have far higher mortality rates than patients who are not ventilated. Some doctors have successfully incorporated hyperbaric oxygen treatment in lieu of ventilation, with great success.

COVID-19 is a steroid-responsive disease. Tragically, health organizations around the world are warning doctors against the use of corticosteroids. Sepsis is also a major cause of death in severe COVID-19 cases. It's not the virus itself that is hurting the host, it's the acute inflammatory dysregulated response to it.

There are two distinct yet overlapping phases of COVID-19 infection.

  1. Phase 1 is the viral replication phase. Typically, patients will only experience mild symptoms, if any, during this phase. At this time, it's important to focus on antiviral therapies.
  2. In Phase 2, the hyperinflammatory immune response sets in, which can result in organ failures (lungs, brain, heart and kidneys). The MATH+ protocol is designed to treat this active phase, but it needs to be administered early enough.

There are three, core pathological processes in COVID-19:

More notes...


"Sorin Draghici, CEO of Advaita Bioinformatics, reports that their incredibly sophisticated Artificial Intelligence platform called iPathwayGuide, using cultured human cell lines infected with COVID-19, and is able to map all the human genes which are activated by this virus.

"Note almost all the activated genes are those that express triggers of inflammation. With this knowledge of the specific COVID inflammatory gene activation combined with knowledge of the gene suppression activity of all known medicines they were able to match the most effective drug for COVID-19 human gene suppression, and that drug is methylprednisolone.

"This must be recognized, as the ability of other corticosteroids to control inflammation in COVID-19 is much less impactful. This is an absolutely critical and historic finding. Many centers are using similar but less effective agents such as dexamethasone or prednisone."

Ascorbic acid (Vitamin C)

Dr. Paul Marik is chief of pulmonary and critical care medicine at the Eastern Virginia Medical School in Norfolk, Virginia.

His sepsis protocol, published in 2017, calls for intravenous vitamin C and a steroid, hydrocortisone, along with thiamine. It has been extraordinarily successful.